681128-50-7 Usage
Uses
Used in Pharmaceutical Research and Development:
(2R,4S)-1-(tert-butoxycarbonyl)-4-fluoropyrrolidine-2-carboxylic acid is used as a potential building block for the development of new drugs. Its fluorine atom and carboxylic acid functional group can be exploited to create novel molecular entities with specific biological activities, addressing unmet medical needs.
Used in Biochemical Research:
In biochemical research, (2R,4S)-1-(tert-butoxycarbonyl)-4-fluoropyrrolidine-2-carboxylic acid can be employed as a synthetic intermediate or a probe molecule to study enzyme mechanisms, protein-ligand interactions, or other biological processes. Its unique structure may provide insights into the molecular basis of various biological phenomena.
Used in Organic Synthesis:
(2R,4S)-1-(tert-butoxycarbonyl)-4-fluoropyrrolidine-2-carboxylic acid is used as a synthetic intermediate in organic chemistry. The tert-butoxycarbonyl group can be selectively removed under mild conditions, revealing the reactive functional groups for further chemical transformations. This property makes it a valuable component in the synthesis of complex organic molecules and natural products.
Used in Drug Delivery Systems:
(2R,4S)-1-(tert-butoxycarbonyl)-4-fluoropyrrolidine-2-carboxylic acid can be utilized in the design of drug delivery systems, where its carboxylic acid functional group can be conjugated to various carriers, such as nanoparticles or polymers. This allows for targeted drug delivery and controlled release, improving the therapeutic efficacy and reducing side effects of the drug molecules.
Check Digit Verification of cas no
The CAS Registry Mumber 681128-50-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,8,1,1,2 and 8 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 681128-50:
(8*6)+(7*8)+(6*1)+(5*1)+(4*2)+(3*8)+(2*5)+(1*0)=157
157 % 10 = 7
So 681128-50-7 is a valid CAS Registry Number.
681128-50-7Relevant articles and documents
INHIBITORS OF ENCEPHALITIC ALPHAVIRUSES
-
Page/Page column 91; 96, (2021/03/13)
Compounds of Formula I and Formula II: pharmaceutical compositions containing them, and use of the compounds as active ingredients to treat infection with alphavirus.
METABOTROPIC GLUTAMATE RECEPTORS 5 MODULATORS AND METHODS OF USE THEREOF
-
Page/Page column 153, (2012/12/13)
Compounds that modulate GluR5 activity and methods of using the same are disclosed.
COMPOUNDS CONTAINING FUSED RINGS WHICH INHIBIT BETA-SECRETASE ACTIVITY AND METHODS OF USE THEREOF
-
Page/Page column 86, (2011/11/01)
The invention provides novel beta-secretase inhibitors and methods for their use, including methods of treating Alzheimer's disease.